Incidence and Management of Gastrointestinal Bleeding With Continuous Flow Assist Devices Ashim Aggarwal, MD, MRCP, Rojina Pant, MD, Shivani Kumar, Priya Sharma, BA, Colleen Gallagher, BSN, Antone J. Tatooles, MD, Pat S. Pappas, MD, Geetha Bhat, MD, PhD The Annals of Thoracic Surgery Volume 93, Issue 5, Pages 1534-1540 (May 2012) DOI: 10.1016/j.athoracsur.2012.02.035 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier survival curves. (A) Kaplan-Meier estimates of overall mortality at 70 months (entire duration of follow-up) among patients with and without gastrointestinal (GI) bleeding. (B) Kaplan-Meier estimates of overall mortality at 12 months in patients with and without GI bleeding. (GIB = gastrointestinal bleeding.) The Annals of Thoracic Surgery 2012 93, 1534-1540DOI: (10.1016/j.athoracsur.2012.02.035) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Pie chart showing the source of GI bleeding. (A) Overall distribution of causes. (B) Causes of upper GI bleeding (UGIB). (C) Causes of lower GI bleeding (LGIB). (AVM = arteriovenous malformation.) The Annals of Thoracic Surgery 2012 93, 1534-1540DOI: (10.1016/j.athoracsur.2012.02.035) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions